Goldman Sachs Chief U.S. Equity Strategist David Kostin sees “no return” coming for stocks in the remainder of the year, ...

Shares of Fulcrum Therapeutics (FULC) jumped 7% post-market after Goldman Sachs upgraded the stock to buy and raised peak ...

The banking sector is in a unique time and place as investors navigate economic conditions, such as higher for longer ...

Another big mover in the index is Amgen, which surged more than 14% last week on a solid earnings report and encouraging test ...

Goldman Sachs (GS) rose on Thursday, registering its seventh straight session in green and recording over a xx% jump over ...

The U.S. stock market’s climb this year probably has stalled for the rest of 2024, even as investors remain optimistic that ...

The online sports betting market saw slower growth in the month of March. A leading analyst shares data and picks the winners ...

S hares of investment bank Goldman Sachs hit an all-time high Friday as the stock built on its longest winning streak in two ...

Nvidia stock is in the news Wednesday after Goldman Sachs increased its price target for NVDA shares in a new note to clients ...

It’s the CPI that has Goldman Sachs’ macro strategist Vickie Chang concerned, as she discusses potential market shocks linked ...

Solomon said that while it was anticipated that the government would spend during COVID lockdowns, “we’re a long way out of ...

Simultaneously, JMP Securities analysts also assumed coverage on IBTA, with a Market Outperform rating and a $130 price target. The investment firm believes that the technology company is transforming ...